296 related articles for article (PubMed ID: 26091979)
1. Pertussis vaccines and the challenge of inducing durable immunity.
Warfel JM; Edwards KM
Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to pertussis vaccines and disease.
Edwards KM; Berbers GA
J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
[TBL] [Abstract][Full Text] [Related]
3. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.
Rieber N; Graf A; Hartl D; Urschel S; Belohradsky BH; Liese J
PLoS One; 2011 Mar; 6(3):e17271. PubMed ID: 21408149
[TBL] [Abstract][Full Text] [Related]
4. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
5. Pertussis vaccines and protective immunity.
Kapil P; Merkel TJ
Curr Opin Immunol; 2019 Aug; 59():72-78. PubMed ID: 31078081
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
7. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
8. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
[TBL] [Abstract][Full Text] [Related]
10. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
Ausiello CM; Cassone A
mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
[TBL] [Abstract][Full Text] [Related]
11. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.
Diavatopoulos DA; Edwards KM
Cold Spring Harb Perspect Biol; 2017 Dec; 9(12):. PubMed ID: 28289059
[TBL] [Abstract][Full Text] [Related]
12. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
[TBL] [Abstract][Full Text] [Related]
13. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
14. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
15. Characterization of co-purified acellular pertussis vaccines.
Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
[TBL] [Abstract][Full Text] [Related]
16. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
17. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2012 Nov; 19(11):1879-86. PubMed ID: 23015649
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.
da Silva Antunes R; Babor M; Carpenter C; Khalil N; Cortese M; Mentzer AJ; Seumois G; Petro CD; Purcell LA; Vijayanand P; Crotty S; Pulendran B; Peters B; Sette A
J Clin Invest; 2018 Aug; 128(9):3853-3865. PubMed ID: 29920186
[TBL] [Abstract][Full Text] [Related]
19. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.
Hendrikx LH; Felderhof MK; Oztürk K; de Rond LG; van Houten MA; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Dec; 30(1):51-8. PubMed ID: 22064265
[TBL] [Abstract][Full Text] [Related]
20. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
